Dimensional Fund Advisors LP increased its stake in shares of Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 3.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 901,707 shares of the electronics maker's stock after buying an additional 31,164 shares during the quarter. Dimensional Fund Advisors LP owned about 0.94% of Dolby Laboratories worth $70,424,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Fifth Third Bancorp boosted its holdings in shares of Dolby Laboratories by 82.7% in the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker's stock valued at $28,000 after purchasing an additional 163 shares in the last quarter. Nisa Investment Advisors LLC boosted its holdings in shares of Dolby Laboratories by 436.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker's stock valued at $29,000 after purchasing an additional 301 shares in the last quarter. Mather Group LLC. boosted its holdings in shares of Dolby Laboratories by 36.8% during the 4th quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock valued at $41,000 after acquiring an additional 142 shares in the last quarter. Headlands Technologies LLC acquired a new stake in shares of Dolby Laboratories during the 4th quarter valued at $57,000. Finally, GAMMA Investing LLC boosted its holdings in shares of Dolby Laboratories by 207.5% during the 4th quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker's stock valued at $61,000 after acquiring an additional 525 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company's stock.
Analysts Set New Price Targets
DLB has been the topic of several recent research reports. StockNews.com downgraded Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a report on Friday, January 31st. Barrington Research reissued an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a report on Thursday, February 13th. Finally, Rosenblatt Securities reissued a "buy" rating and set a $100.00 price objective on shares of Dolby Laboratories in a report on Thursday, January 30th.
Check Out Our Latest Research Report on DLB
Insider Buying and Selling at Dolby Laboratories
In other Dolby Laboratories news, CMO Todd Pendleton sold 18,121 shares of the stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $83.75, for a total transaction of $1,517,633.75. Following the completion of the sale, the chief marketing officer now owns 37,290 shares of the company's stock, valued at approximately $3,123,037.50. This represents a 32.70 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Ryan Nicholson sold 7,000 shares of the stock in a transaction that occurred on Wednesday, February 5th. The stock was sold at an average price of $84.07, for a total value of $588,490.00. Following the transaction, the chief accounting officer now owns 29,758 shares in the company, valued at $2,501,755.06. The trade was a 19.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 38.39% of the company's stock.
Dolby Laboratories Price Performance
Dolby Laboratories stock opened at $76.83 on Thursday. The stock's 50 day moving average is $77.97 and its 200 day moving average is $78.29. Dolby Laboratories, Inc. has a one year low of $66.35 and a one year high of $89.66. The firm has a market cap of $7.33 billion, a P/E ratio of 28.25 and a beta of 0.94.
Dolby Laboratories Profile
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.